CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
12 research outputs found
Overall survival in patients with glioblastoma before and after bevacizumab approval.
Author
Alexander R Macalalad
Annie Guerin
+7 more
Antonio Marcilio Padula Omuro
Arliene Ravelo
Derek Richard Johnson
Joon H. Uhm
Nicolas Sommer
Raluca Ionescu-Ittu
Sherry Shi
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Phase IB trial of carboxyamidotriazole orotate (CTO) and temozolomide for recurrent malignant glioma (MG): A novel mechanism for modulation of multiple oncogenic pathways.
Author
Antonio Marcilio Padula Omuro
Barry Douglas Anderson
+8 more
Elena Pentsova
Greg Gorman
Lisa Marie DeAngelis
Matthew Hiram Taylor
Rashida A. Karmali
Sean McLean
Thomas Joseph Kaley
Walter John Urba
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143.
Author
Alfredo Daniel Voloschin
Antonio Marcilio Padula Omuro
+11 more
David A Hafler
David A. Reardon
Gordana Vlahovic
Joachim M. Baehring
John H. Sampson
Joseph Grosso
Michael Lim
Prashni Paliwal
Solmaz Sahebjam
Timothy F. Cloughesy
Vlad Coric
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Safety and activity of nivolumab (nivo) monotherapy and nivo in combination with ipilimumab (ipi) in recurrent glioblastoma (GBM): Updated results from checkmate-143.
Author
Alfredo Daniel Voloschin
Antonio Marcilio Padula Omuro
+11 more
Christopher T. Harbison
David A. Reardon
Gordana Vlahovic
Joachim M. Baehring
John H. Sampson
Lewis C. Strauss
Michael Lim
Prashni Paliwal
Robert Raymond Latek
Solmaz Sahebjam
Timothy Francis Cloughesy
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Multicenter Phase IB trial of carboxyamidotriazole orotate (CTO) combined with temozolomide (TMZ) for recurrent glioblastoma (GBM) and other malignant gliomas (MG).
Author
Andrew McKeown
Antonio Marcilio Padula Omuro
+13 more
Elena Pentsova
Greg Gorman
Igor T. Gavrilovic
Ingo K. Mellinghoff
Jessica Hansen
Linda M. Bavisotto
Lisa Marie DeAngelis
Malbora Manne
Mariza Daras
Michael Lamson
Rashida A. Karmali
Thomas Joseph Kaley
Xuling Lin
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
A phase 2 study of orally administered PLX3397 in patients with recurrent glioblastoma.
Author
Adhirai Marimuthu
Antonio Marcilio Padula Omuro
+12 more
Arie Perry
Brian West
Henry H Hsu
Howard Colman
Joanna J Phillips
John Frederick De Groot
Keith B. Nolop
Keith L. Ligon
Lakshmi Nayak
Michael Prados
Nicholas A. Butowski
Timothy F. Cloughesy
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Patterns of response and relapse of primary central nervous system lymphomas (PCNSL) following first line of high-dose methotrexate-based chemotherapy (hdMTX): Analysis of a prospective ANOCEF randomized phase II trial.
Author
Antonio Marcilio Padula Omuro
Carole Soussain
+14 more
Caroline Houillier
Emeline Tabouret
Emmanuel Gyan
Herve Ghesquieres
Khê Hoang-Xuan
Luc Taillandier
Marie Blonski
Marie-Laure Tanguy
Nadine Martin-Duverneuil
Olivier L. Chinot
Pierre Soubeyran
Remy Gressin
Roch Houot
Vincent Delwail
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Phenotypic correlation of tumor uptake of exogenous glutamine radiotracer versus tumor mutational status.
Author
Alicia Lashley
Anas Younes
+16 more
Antonio Marcilio Padula Omuro
Craig B. Thompson
David Paul Kelsen
Hank Kung
Hanwen Zhang
Ingo K. Mellinghoff
James Hsieh
James J. Harding
Jason Stuart Lewis
John F. Gerecitano
Louise Harris
Mark Dunphy
Pat Zanzonico
Sean Carlin
Serge K. Lyashchenko
Sriram Venneti
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
Author
Alissa A. Thomas
Antonio Marcilio Padula Omuro
+14 more
Eli L. Diamond
Greg Gorman
Ingo K. Mellinghoff
Katharine Anne McNeill
Kathryn Beal
Linda M. Bavisotto
Lisa Marie DeAngelis
Michael Lamson
Rashida A. Karmali
Robert J. Young
Thomas Joseph Kaley
Timothy An-thy Chan
Xuling Lin
Yoshiya Yamada
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Brain metastases
Author
AH Mintz
Antonio Marcilio Padula Omuro
+20 more
C Christodoulou
CJ Vecht
D Antonadou
D Bafaloukos
D Schiff
EL Chang
JB Posner
KA Sepkowitz
Lauren Eileen Abrey
LE Abrey
LE Gaspar
LJ Schouten
LM DeAngelis
PA Forsyth
PK Sneed
RA Cairns
RA Patchell
RA Patchell
RK Bindal
S Villa
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
1
2